NasdaqGS - Nasdaq Real Time Price USD
Exelixis, Inc. (EXEL)
43.03
+0.66
+(1.56%)
At close: June 6 at 4:00:01 PM EDT
43.00
-0.03
(-0.07%)
After hours: June 6 at 7:58:25 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
842,586
699,971
333,324
362,614
400,804
Investing Cash Flow
-178,812
-116,783
-26,955
-524,414
-42,884
Financing Cash Flow
-739,583
-628,808
-546,052
586
-14,801
End Cash Position
183,752
217,374
262,994
502,677
663,891
Income Tax Paid Supplemental Data
--
170,482
185,658
127,870
12,960
Capital Expenditure
-70,446
-66,185
-162,969
-138,456
-64,225
Repayment of Debt
0
--
--
--
--
Repurchase of Capital Stock
-750,592
-652,033
-550,378
0
0
Free Cash Flow
772,140
633,786
170,355
224,158
336,579
12/31/2021 - 4/17/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADMA ADMA Biologics, Inc.
20.61
+3.36%
CPRX Catalyst Pharmaceuticals, Inc.
25.87
+2.01%
ARGX argenx SE
585.93
+0.92%
INCY Incyte Corporation
68.77
+2.28%
ALNY Alnylam Pharmaceuticals, Inc.
300.83
-2.33%
TGTX TG Therapeutics, Inc.
40.06
+1.93%
ACAD ACADIA Pharmaceuticals Inc.
21.98
+3.00%
HALO Halozyme Therapeutics, Inc.
54.25
+1.31%
AKRO Akero Therapeutics, Inc.
54.28
+0.63%
BMRN BioMarin Pharmaceutical Inc.
56.65
+2.50%